1. Home
  2. VTAK vs SPHL Comparison

VTAK vs SPHL Comparison

Compare VTAK & SPHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Catheter Precision Inc.

VTAK

Catheter Precision Inc.

HOLD

Current Price

$2.00

Market Cap

4.1M

Sector

Health Care

ML Signal

HOLD

Logo Springview Holdings Ltd Class A Ordinary Shares

SPHL

Springview Holdings Ltd Class A Ordinary Shares

N/A

Current Price

$2.14

Market Cap

3.5M

ML Signal

N/A

Company Overview

Basic Information
Metric
VTAK
SPHL
Founded
2002
2002
Country
United States
Singapore
Employees
N/A
71
Industry
Medical/Dental Instruments
Homebuilding
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
4.1M
3.5M
IPO Year
2018
2024

Fundamental Metrics

Financial Performance
Metric
VTAK
SPHL
Price
$2.00
$2.14
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
34.4K
52.4K
Earning Date
11-13-2025
12-29-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$730,000.00
$5,956,226.00
Revenue This Year
$822.86
N/A
Revenue Next Year
$168.42
N/A
P/E Ratio
N/A
N/A
Revenue Growth
82.96
N/A
52 Week Low
$1.49
$1.92
52 Week High
$15.68
$62.40

Technical Indicators

Market Signals
Indicator
VTAK
SPHL
Relative Strength Index (RSI) 48.55 47.79
Support Level $1.97 $2.04
Resistance Level $2.10 $2.34
Average True Range (ATR) 0.17 0.25
MACD 0.02 -0.11
Stochastic Oscillator 65.96 17.97

Price Performance

Historical Comparison
VTAK
SPHL

About VTAK Catheter Precision Inc.

Catheter Precision Inc is engaged in design, manufacture and sale of new and innovative medical technologies primarily focused in the field of cardiac electrophysiology, or EP. The Company's primary product is the View into Ventricular Onset System (VIVO or VIVO System), which is a non-invasive imaging system that offers 3D cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients with structurally normal hearts prior to EP procedures. The VIVO system has achieved a CE Mark allowing it to be commercialized in the European Union and has been placed at several hospitals in Europe. Its newest product, the Surgical Vessel Closing Pressure Device (LockeT), is a suture retention device indicated for wound healing by distributing suture tension.

About SPHL Springview Holdings Ltd Class A Ordinary Shares

Springview Holdings Ltd is a company that conducts its operations through its indirect wholly-owned subsidiary which designs and constructs residential and commercial buildings in Singapore. It also provides four main types of works which includes new construction, reconstruction, Additions and Alterations (A&A), and other general contracting services such as renovation and design consultation. The company operates and manages its business as a single segment - in the development of construction projects. It derives maximum revenue from its Residential Customers.

Share on Social Networks: